Adenovirus-mediated gene transfer into striated muscles (original) (raw)

References

  1. Acsadi G, Jiao S, Jani A, Duke D, Williams P, Chong W, Wolff JA (1991) Direct gene transfer and expression into rat heart in vivo. New Biol 3:71–81
    Google Scholar
  2. Acsadi G, Dickson G, Love D, Jani A, Gurusinghe A, Walsh FS, Wolff JA, Davies KE (1991) Human dystrophin expression in mdx mice after injection of DNA constructs. Nature 352:815–818
    Google Scholar
  3. Acsadi G, Jani A, Massie B, Simoneau M, Holland P, Blaschuk K, Karpati G (1994) A differential efficiency of adenovirus-mediated in vivo gene transfer into skeletal muscle cells of different maturity. Hum Mol Genet 3:579–584
    Google Scholar
  4. Acsadi G, Jani A, Huard J, Blaschuk K, Massie B, Holland P, Lochmüller H, Karpati G (1994) Cultured human myoblasts and myotubes show markedly different transducibility by replication-defective adenovirus recombinants. Gene Ther 1:338–340
    Google Scholar
  5. Acsadi G, Jani A, Lochmüller H, Huard J, Massie B, Prescott S, Simoneau M, Petrof B, Karpati G (1995) Efficient dystrophin expression in muscles of mdx mice after adenovirus-mediated in vivo gene transfer. (submitted)
  6. Ahn AH, Kunkel LM (1993) The structural and functional diversity of dystrophin. Nature Genet 2:283–291
    Google Scholar
  7. Akkusjarvi GC, Svensson C, Nygard O (1987) A mechanism by which adenovirus virus-associated RNA1 controls translation in a transient expression assay. Mol Cell Biol 7:549–551
    Google Scholar
  8. Akli S, Caillaud C, Vigne E, Stratford-Perricaudet LD, Poenaru L, Perricaudet M, Kahn A, Peschanski MR (1993) Transfer of a foreign gene into the brain using adenovirus vectors. Nature Genet 3:224–234
    Google Scholar
  9. Alameddine HS, Quantin B, Cartaud A, Dehaupas M, Mandel JL, Fardeau M (1994) Expression of a recombinant dystrophin in mdx mice using adenovirus vector. Neuromuscul Disord 4:193–203
    Google Scholar
  10. Alkhatib G, Massie B, Briedis DJ (1988) Expression of bicistronic measles virus P/CmRNA by using hybrid adenoviruses: levels of C protein synthesized in vivo are unaffected by the presence or absence of the upstream P initiator codon. J Virol 62:4059–4069
    Google Scholar
  11. Alkhatib G, Briedis DJ (1988) High-level eukaryotic in vivo expression of biologically active measles virus hemagglutinin by using an adenovirus type 5 helper-free vector system. J Virol 62:2718–2727
    Google Scholar
  12. Anderson FW (1992) Human gene therapy. Science 256:808–813
    Google Scholar
  13. Babiss LE, Ginsberg HS, Darnell JE (1985) Adenovirus E1B proteins are required for accumulation of late viral mRNA and for effects on cellular mRNA translation and transport. Mol Cell Biol 5:2552–2558
    Google Scholar
  14. Bai M, Campisi L, Freimuth P (1994) Vitronectin receptor antibodies inhibit infection of HeLa cells and A549 cells by adenovirus type 12 but not by adenovirus type 2. J Virol 68:5925–5932
    Google Scholar
  15. Ballay A, Levrero M, Buandia MA, Tiollais P, Perricaudet M (1985) In vitro and in vivo synthesis of the hepatitis B virus surface antigen and of the receptor for polymerized human serum albumin from recombinant adenoviruses. EMBO J 4:3861–3865
    Google Scholar
  16. Barr E, Carroll J, Kalynych AM, Tripathy SK, Kozarsky K, Wilson JM, Liden JM (1994) Efficient catheter-mediated gene transfer into the heart using replication-defective adenovirus. Gene Ther 1:51–58
    Google Scholar
  17. Beggs AH, Kunkel LM (1990) Improved diagnosis of Duchenne/Becker muscular dystrophy. J Clin Invest 85:613–619
    Google Scholar
  18. Berk AJ (1986) Functions of adenovirus E1A. Cancer Surv 5:367–387
    Google Scholar
  19. Berkner KL, Sharp PA (1984) Expression of dihydrofolate reductase and of the adjacent E1B region in an Ad5-dihydrofolate reductase recombinant virus. Nucl Acids Res 12:1925–1941
    Google Scholar
  20. Berkner KL, Sharp PA (1985) Effect of the tripartite leader on synthesis of a non-viral protein in an adenovirus 5 recombinant. Nucl Acids Res 13:841–857
    Google Scholar
  21. Berkner KL, Schaffhausen GS, Roberts TM, Sharp PA (1987) Abundant expression of polyomavirus middle T antigen and dihydrofolate reductase in an adenovirus recombinant. J Virol 61:1213–1220
    Google Scholar
  22. Berkner KL (1988) Development of adenovirus vectors for the expression of heterologous genes. BioTechniques 6:616–629
    Google Scholar
  23. Bett A, Prevec L, Graham F (1993) Packaging capacity and stability of human adenovirus type 5 vectors. J Virol 67:5911–5921
    Google Scholar
  24. Bett AJ, Haddara W, Prevec L, Graham FL (1994) An efficient and flexible system for construction of adenovirus vectors with insertion or deletions in early regions 1 and 3. Proc Natl Acad Sci USA 91:8802–8806
    Google Scholar
  25. Branton PE, Baylay ST, Graham FL (1985) Transformation by human adenoviruses. Biochim Biophys Acta 780:67–94
    Google Scholar
  26. Bridge E, Ketner G (1989) Redundant control of adenovirus late gene expression by early region 4. J Virol 63:631–638
    Google Scholar
  27. Bulfield G, Siller WG, Wight PAL, Moore KJ (1984) X-chromosome-linked muscular dystrophy (MDX) in the mouse. Proc Natl Acad Sci USA 81:1189–1192
    Google Scholar
  28. Byers TJ, Kunkel LM, Watkins SC (1991) The subcellular distribution of dystrophin in mouse skeletal cardiac and smooth muscle. J Cell Biol 115:411–421
    Google Scholar
  29. Chroboczek J, Bieber F, Jacrot B (1992) The sequence of the genome of adenovirus type 5 and its comparison with the genome of adenovirus type 2. Virology 186:280–285
    Google Scholar
  30. Coovert DD, Burghes AHM (1994) Gene therapy for muscle diseases. Current Opinion Neurol 7:463–470
    Google Scholar
  31. Cox GA, Cole NM, Matsumure K, Phelps SF, Hauschka SD, Campbell KP, Faulkner JA, Chamberlain JS (1993) Overexpression of dystrophin in transgenic mdx mice eliminates dystrophic symptoms without toxicity. Nature 364:725–729
    Google Scholar
  32. Crystal RG, McElvaney NG, Rosenfeld MA, Chu C-S, Mastrangeli A, Hay JG, Brody SL, Jaffe HA, Eissa NT, Danel C (1994) Administration of an adenovirus containing the human CFTR cDNA to the respiratory tract of individuals with cystic fibrosis. Nature Genet 8:42–51
    Google Scholar
  33. Danko I, Fritz JD, Latendresse JS, Herweijer H, Schultz E, Wolff JA (1993) Dystrophin expression improves myofiber survival in mdx muscle following intramuscular plasmid DNA injection. Hum Mol Genet 2:2055–2061
    Google Scholar
  34. Davidson D, Hassell JA (1987) Overproduction of polyomavirus middle T antigen in mammalian cells through the use of an adenovirus vector. J Virol 61:1226–1239
    Google Scholar
  35. Davidson BL, Allen ED, Kozarsky KF, Wilson JM, Roessler BJ (1993) A model system for in vivo gene transfer into the central nervous system using an adenoviral vector. Nature Genet 3:219–223
    Google Scholar
  36. Davis AR, Kostek B, Mason BB, Hsiao CL, Morin J, Dheer SK, Hung PP (1985) Expression of hepatitis B surface antigen with a recombinant adenovirus. Proc Natl Acad Sci USA 82:7560–7564
    Google Scholar
  37. Defer C, Belin M-T, Caillet-Boudin M-L, Boulanger P (1990) Human adenovirus-host cell interactions: comparative study with members of subgroups B and C. J Virol 64:3661–3673
    Google Scholar
  38. Dhawan J, Pan LC, Pavlath GK, Travis MA, Lanctot AM, Blau HM (1991) Systemic delivery of human growth hormone by injection of genetically engineered myoblasts. Science 254:942–947
    Google Scholar
  39. Dunckley MG, Love DR, Davies KE, Walsh FS, Morris GE, Dickson G (1992) Retroviral-mediated transfer of a dystrophin minigene into mdx mouse myoblasts in vitro. FEBS Lett 296:128–134
    Google Scholar
  40. Engelhardt JF, Yang Y, Stratford-Perricaudet LD, Allen LD, Kozarsky K, Perricaudet M, Yankaskas JR, Wilson JM (1993) Direct gene transfer of human CFTR into human bronchial epithelia of xenografts with E1-deleted adenoviruses. Nature Genet 4:27–34
    Google Scholar
  41. Engelhardt JF, Litzky L, Wilson JM (1994) Prolonged transgene expression in Cotton rat lung with recombinant adenoviruses defective in E2A. Hum Gene Ther 5:1217–1229
    Google Scholar
  42. England SB, Nicholson LVB, Johnson MA, Forrest SM, Love DR, Zubrzyczka-Gaarn EE, Bulman DE, Harris JB, Davies KE (1990) Very mild muscular dystrophy associated with the deletion of 46% of dystrophin. Nature 343:180–182
    Google Scholar
  43. Ervasti JM, Campbell KP (1991) Membrane organization of the dystrophin-glycoprotein complex. Cell 66:1121–1131
    Google Scholar
  44. Flint SJ, Broker TR (1981) Lytic infection by adenoviruses. In: Tooze J (ed) DNA tumor viruses. Cold Spring Harbor Laboratory, New York, pp 443–546
    Google Scholar
  45. Friedman T (1989) Progress toward human gene therapy. Science 244:1275–1281
    Google Scholar
  46. Frisch SM, Reich R, Collier IE, Genrich LT, Martin G, Goldberg GI (1990) Adenovirus E1A represses protease gene expression and inhibits metastasis in human tumor cell. Oncogene 5:75–83
    Google Scholar
  47. Frisch SM (1991) Antioncogenic effect of adenovirus E1A in human tumor cells. Proc Natl Acad Sci USA 88:9077–9081
    Google Scholar
  48. Gardner-Medwin D, Walton J (1994) The muscular dystrophies. In: Walton J, Karpati G, Hilton-Jones D (eds) Disorders of voluntary muscle. Churchill Livingstone, Edinburgh, pp 543–594
    Google Scholar
  49. Garnier A, Cote J, Nadeau I, Kamen A, Massie B (1994) Scale-up of the adenovirus expression system for production of recombinanl protein in human 293S cells. Cytotech 15; 145–155
    Google Scholar
  50. Gaynor RB, Berk AJ (1983) _Cis_-acting induction of adenovirus transcription. Cell 33:683–693
    Google Scholar
  51. Ginsberg HS (ed) (1984) The adenoviruses. Plenum, New York
    Google Scholar
  52. Ginsberg H, Lundholm-Beauchamp U, Horswood R, Pernis B, Wold W, Chanock R, Prince G (1989) Role of early region 3 (E3) in palhogenesis of adenovirus disease. Proc Natl Acad Sci USA 86:3823–3827
    Google Scholar
  53. Ghadge GD, Swaminathan S, Katze MG, Thimmapaya B (1991) Binding of the adenovirus VAI RNA to the interferon induced 68-kD protein kinase correlated with function. Proc Natl Acad Sci USA 88:7140–7144
    Google Scholar
  54. Gluzman Y, Reichl H, Solnick D (1982) Helper-free adenovirus type 5 vectors. In: Gluzman Y (ed) Eukaryotic viral vectors. Cold Spring Harbor Laboratory, New York; pp 187–192
    Google Scholar
  55. Gooding LR, Elmore LW, Tollefson AE, Brady HA, Wold WSM (1988) A 14 700 MW protein from the E3 region of adenovirus inhibits cytolysis by tumor necrosis factor. Cell 53:341–346
    Google Scholar
  56. Gosh-Choudhury G, Haj-Ahmad Y, Brinkley P, Rusy J, Graham FL (1986) Human adenovirus cloning vectors based on Infectious bacterial plasmids. Gene 50:161–167
    Google Scholar
  57. Gosh-Choudhury G, Haj-Ahmad Y, Graham FL (1987) Protein IX a minor component of human adenovirus capsid is essential for the packaging of full length genomes. EMBO J 6:1733–1739
    Google Scholar
  58. Gosztonyi G, Dietzschold B, Kao M, Rupprecht CE, Ludvig H, Koprowski H (1993) Rabies and Borna disease. A comparative pathogenetic study of two neurovirulent agents. Laboratory Investig 68:285–295
    Google Scholar
  59. Graham FL (1984) Transformation and oncogenicity of human adenoviruses. In: Ginsberg HS (ed) The adenoviruses. Plenum, New York, pp 339–398
    Google Scholar
  60. Graham FL (1987) Growth of 293 cells in suspension culture. J Gen Virol 68:937–940
    Google Scholar
  61. Graham FL, Eb AJ van der (1973) A new technique for the assay of infectivity of human adenovirus 5. Virology 52:456–467
    Google Scholar
  62. Graham FL, Prevec L (1991) Manipulation of adenovirus vectors. In. Murray EJ (ed) Gene transfer and expression protocols. Humana, Clifton, pp 109–128
    Google Scholar
  63. Graham FL, Prevec L (1992) Adenovirus-based expression vectors and recombinant vaccines. In: Ellis RW (ed) Vaccines: new approaches to immunological problems. Butterworth-Heinemann, Boston, pp 363–389
    Google Scholar
  64. Graham FL, Smiley J, Russel WC, Nairn R (1977) Characteristics of a human cell line transformed by DNA from human adenovirus 5. J Gen Virol 36:59–72
    CAS PubMed Google Scholar
  65. Gräble M, Hearing P (1992) Cis and trans requirements for the selective packaging of the adenovirus type 5 DNA. J Virol 66:723–731
    Google Scholar
  66. Greber UF, Willetts M, Webster P, Helenius A (1993) Stepwise dismantling of adenovirus 2 during entry into cells. Cell 75:477–486
    Google Scholar
  67. Green M, Pina M, Kimes RC (1966) Biochemical studies on adenovirus multiplication. XII. Plaquing efficiencies of purified human adenoviruses. Virology 31:562–565
    Google Scholar
  68. Grounds MD (1991) Towards understanding skeletal muscle regeneration. Pathol Res Pract 118:1–22
    Google Scholar
  69. Grubb BR, Pickles RJ, Ye H, Yankaskas JR, Vick RN, Engelhardt JF, Wilson JM, Johnson LG, Boucher RC (1994) Inefficient gene transfer by adenovirus vector to cystic fibrosis airway epithelia of mice and humans. Nature 371:802–806
    Google Scholar
  70. Gutch MJ, Reich NC (1991) Repression of the interferon signal transduction pathway by the adenovirus E1A oncogene. Proc Natl Acad Sci USA 88:7913–7917
    Google Scholar
  71. Haj-Ahmad Y, Graham FL (1986) Development of a helper independent human adenovirus vector and its use in the transfer of the herpes simplex virus thymidine kinase gene. J Virol 57:267–274
    Google Scholar
  72. Hauser MS, Phelps SF, Chamberlain JS (1994) Expression of dystrophin minigenes in the muscles of mdx mice partially prevents the development of dystrophic symptomes. Am J Hum Genet 55:A47
    Google Scholar
  73. Hay RT (1985) The origin of adenovirus DNA replication: minimal DNA sequence requirement in vivo. EMBO J 4:421–426
    Google Scholar
  74. Haynes RO (1992) Integrins: versatility modulation and signaling in cell adhesion. Cell 69:11–25
    Article CAS PubMed Google Scholar
  75. Henderson CE, Bloch-Gallego E, Camu W, Gouin A, Lemeulle C, Mettling C (1994) Motoneuron survival factors: biological roles and therapeutic potential. Neuromuscul Disord 3:455–458
    Google Scholar
  76. Herisse J, Rigolet M, Dupont S, Galibert F (1981) Nucleotide sequence of adenovirus 2 DNA fragment encoding for the carboxylic region of the fiber protein and the entire E4 region. Nucl Acids Res 9:4023–4042
    Google Scholar
  77. Hoffman EP, Brown RH, Kunkel LM (1987) Dystrophin: the protein product on the Duchenne muscular dystrophy locus. Cell 51:919–928
    Google Scholar
  78. Huard J, Acsadi G, Jani A, Massie B, Karpati G (1994) Gene transfer into skeletal muscles by isogenic myoblasts. Hum Gene Ther 5:949–958
    Google Scholar
  79. Huard J, Lochmüller H, Acsadi G, Jani A, Massie B, Karpati G (1995) The route of administration is a major determinant of the transduction efficiency of rat tissues by adenoviral recombinants. Gene Ther 2:107–115
    Google Scholar
  80. Ibraghimov-Beskrovnaya O, Ervasti JM, Leveille CJ, Slaughter CA, Sernett SW, Campbell KP (1992) Primary structure of dystrophin-associated glycoproteins linking dystrophin to the extracellular matrix. Nature 355:696–702
    Google Scholar
  81. Jacobs SC, Stephenson JR, Wilkinson GWG (1992) High-level expression of the tick-borne encephalitis virus NS1 protein by using an adenovirus-based vector protection elicited in a murine model. J Virol 66:20865–2095
    Google Scholar
  82. Johnson DC, Goutam G-C, Smiley JR, Fallis L, Graham F (1988) Abundant expression of herpes simplex virus glycoprotein gB using an adenovirus vector. Virology 164:1–14
    Google Scholar
  83. Kalvakolanu DVR, Bandyopadhyay SK, Harter ML, Sen GC (1991) Inhibition of interferon-inducible gene expression by adenovirus E1A proteins: block in transcriptional complex formation. Proc Natl Acad Sci USA 88:7459–7463
    Google Scholar
  84. Karpati G, Pouliot Y, Carpenter S (1988) Expression of immunoreactive major histocompatibility complex products in human skeletal muscles. Ann Neurol 23:64–72
    Google Scholar
  85. Karpati G, Carpenter S, Prescott S (1988) Small-caliber skeletal muscle fibers do not suffer necrosis in mdx mouse dystrophy. Muscle Nerve 11:795–803
    Google Scholar
  86. Karpati G, Acsadi G (1993) The potential for gene therapy in Duchenne muscular dystrophy and other genetic muscle diseases. Muscle Nerve 16:1141–1153
    Google Scholar
  87. Karpati G, Adjukovic D, Arnold D, Gledhill RB, Guttmann R, Holland P, Koch PA, Shoubridge E, Spence D, Vanasse M, Watters GV, Abrahamowicz M, Duff C, Worton RG (1993) Myoblast transfer in Duchenne muscular dystrophy. Ann Neurol 34:8–17
    Google Scholar
  88. Karpati G, Acsadi G (1994) The principles of gene therapy in Duchenne muscular dystrophy. Clin Invest Med 17:499–509
    Google Scholar
  89. Kelly TJ (1984) Adenovirus DNA replication. In: Ginsberg HS (ed) The adenoviruses. Plenum, New York, pp 271–308
    Google Scholar
  90. Koenig M, Hoffman EP, Bertelson CJ, Monaco AP, Feener C, Kunkel LM (1987) Complete cloning of the Duchenne muscular dystrophy (DMD) cDNA and preliminary genomic organization of the DMD gene in normal and affected individuals. Cell 50:509–517
    Google Scholar
  91. Kornegay JN, Tuler SM, Miller DM, Levesque DC (1988) Muscular dystrophy in a litter of golden retriever dogs. Muscle Nerve 11:1056–1064
    Google Scholar
  92. Kovesdi I, Reichel R, Nevins JR (1986) Identification of a cellular transcription factor involved in E1A transactivation. Cell 45:219–228
    Google Scholar
  93. Lamarche N, Massie B, Richer M, Paradis H, Langelier M (1990) High level of expression in 293 cells of herpes simplex virus type 2 ribonucleotide reductase subunit 2 using an adenovirus vector. J Gen Virol 71:1785–1792
    Google Scholar
  94. Lefebvre S, Bürglen L, Reboullet S, Clermont O, Burlet P, Viollet L, Benichou B, Cruaud C, Millasseau P, Zeviani M, La Paslier D, Frézal J, Cohen D, Weissenbach J, Munnich A, Melki J (1995) Identification and characterization of a spinal muscular atrophy-determining gene. Cell 80:155–165
    Google Scholar
  95. Levrero M, Barban V, Manteca S, Ballay A, Balsamo C, Avantaggiati ML, Natoli G, Skellekens H, Tiollais P, Perricaudet M (1991) Defective and nondefective adenovirus vectors for expressing foreign genes in vitro and in vivo. Gene 101:195–202
    Google Scholar
  96. Lin H, Parmacek MS, Morle G, Bolling S, Leiden JM (1990) Expression of recombinant genes in myocardium in vivo after direct injection of DNA. Circulation 82:2217–2221
    Google Scholar
  97. Lisovoski F, Cadusseau J, Akli S, Caillaud C, Vigne E, Poenaru L, Stratford-Perricaudet L, Perricaudet M, Kahn A, Peschanski M (1994) In vivo transfer of a marker gene to study motoneural development. Dev Neurosci NeuroReport 5:1069–1072
    Google Scholar
  98. Lochmüller H, Jani A, Huard J, Prescott S, Simoneau M, Massie B, Karpati G, Acsadi G (1994) Emergence of early region 1 (El)-containing replication competent adenovirus in stocks of replication defective adenovirus recombinants (ΔE1+ΔE3) during multiple passages in 293 cells. Hum Gene Ther 5:1485–1491
    Google Scholar
  99. Love DR, Hill DF, Dickson G, Spurr NK, Byth BC, Marsden RF, Walsh FS, Edwards YH, Davies KE (1989) An autosomal transcript in skeletal muscle with homology to dystrophin. Nature 339:55–58
    Google Scholar
  100. Maizel JV, White DO, Scharff MD (1968) The polypeptides of adenovirus. II. Soluble proteins cores top components and the structure of the virion. Virology 36:126–136
    Google Scholar
  101. Mason BB, Davis AR, Bhat BM, Chengalvala M, Lubeck MD, Zandle G, Kostek B, Cholodofsky S, Dheer S, Molnar Kimber K, Mizutani S, Hung PP (1990) Adenovirus vaccine vectors expressing hepatitis B surface antigen: importance of regulatory elements in the adenovirus major late intron. Virology 177:452–461
    Google Scholar
  102. Mansour SL, Grodzicker T, Tjian R (1985) An adenovirus vector system used to express polyoma virus tumor antigens. Proc Natl Acad Sci USA 82:1359–1363
    Google Scholar
  103. Massie B, Gluzman Y, Hassell JA (1986) Construction of a helper-free recombinant adenovirus that expresses polyomavirus large T antigen. Mol Cell Biol 6:2872–2883
    Google Scholar
  104. Massie B, Dionne J, Lamarche N, Fleurent J, Langlier Y (1995) Improved adenovirus vector produces HSV ribonucleotide reductase R1 and R2 subunits very efficiently, (submitted)
  105. Matsumura K, Campbell KP (1994) Dystrophin-glycoprotein complex: its role in the molecular pathogenesis of muscular dystrophies. Muscle Nerve 17:2–15
    Google Scholar
  106. McDermott MR, Graham FL, Hanke T, Jonhson DC (1989) Protection of mice against lethal challenge with herpes simplex virus by vaccination with an adenovirus vector expressing HSV glycoprotein B. Virology 169:244–247
    Google Scholar
  107. Michael SI, Curiel DT (1994) Strategies to achieve targeted gene delivery via the receptor-mediated endocytosis pathway. Gene Ther 1:223–232
    Google Scholar
  108. Mittereder N, Yei S, Bachurski C, Cupoletti J, Whitsett JA, Tolstoshev P, Trapnell BC (1994) Evaluation of the efficacy and safety of in vitro adenovirus-mediated transfer of the human cystic fibrosis transmembrane conductance regulator cDNA. Hum Gene Ther 5:719–729
    Google Scholar
  109. Monaco AP, Bertelson CJ, Leichti-Gallati S, Moser H, Kunkel LM (1988) An explanation for the phenotypic differences between patients bearing partial deletion of the DMD locus. Genomics 2:90–95
    Google Scholar
  110. Montell C, Fisher EF, Caruthers MH, Berk AJ (1982) Resolving the functions of of overlapping genes by site-specific mutagenesis at a mRNA splice site. Nature 295:380–384
    Google Scholar
  111. Morgan JE (1994) Cell and gene therapy in Duchenne Muscular dystrophy. Hum Gene Ther 5:165–173
    Google Scholar
  112. Mulligan RC (1993) The basic science of gene therapy. Science 260:926–932
    Google Scholar
  113. Nevins JR (1987) Regulation of early adenovirus gene expression. Microbiol Rev 51:419–430
    Google Scholar
  114. Nicholson LVB (1994) Molecular biology of muscle — the generation of protein diversity. In: Walton J, Karpati G, Hilton-Jones D (eds) Disorders of voluntary muscle. Churchill Livingstone, Edinburgh, pp 63–85
    Google Scholar
  115. Pavlath GK, Rich K, Webster SG, Blau HM (1989) Localization of muscle gene products in nuclear domains. Nature 337:570–573
    Google Scholar
  116. Persson R, Wohlfart C, Swensson U, Everitt E (1985) Virusreceptor interaction in the adenovirus system: Characterization of positive cooperative binding of virions on tn HeLa cells. J Virol 54:92–97
    Google Scholar
  117. Philipson L (1961) Adenovirus assay by the fluorescent cellcounting procedure. Virology 15:263–268
    Google Scholar
  118. Pierschbacher MD, Rouslahti E (1984) Cell attachment activity of fibronectin can be duplicated by small synthetic fragments of the molecule. Nature 309:30–33
    Google Scholar
  119. Plank C, Oberhauser B, Mechtler K, Koch C, Wagner E (1994) The influence of endosome-disruptive peptides on gene transfer using synthetic virus-like gene transfer systems. J Biol Chem 269:12916–12924
    Google Scholar
  120. Qualikene W, Gonin P, Eloit M (1994) Short and long term dissemination of deletion mutants of adenovirus in permissive (cotton rat) and non-permissive (mouse) species. J Gen Virol 75:2765–2768
    Google Scholar
  121. Quantin B, Stratford-Perricaudet LD, Tajbakhsh S, Mandel JL (1992) Adenovirus as an expression vector in muscle cells in vivo. Proc Natl Acad Sci USA 89:2581–2584
    Google Scholar
  122. Ragot T, Vincent N, Chafey P, Vigne E, Gilgenkrantz H, Couton D, Cartaud J, Briand P, Kaplan J, Perricaudet M, Kahn A (1993) Efficient adenovirus-mediated transfer of a human minidystrophin gene to skeletal muscle of mdx mice. Nature 361:647–650
    Google Scholar
  123. Rainbow AJ, Castillo JE (1992) Homologous recombination of adenovirus DNA in mammalian cells: enhanced recombination following UV-irradiation of the virus. Mutation Res DNA Repair 274:201–210
    Google Scholar
  124. Rich DP, Couture LA, Cardoza RJ, Guiggio VM, Armentano D, Espino PC, Hehir K, Welsh MJ, Smith AE, Gregory RJ (1993) Development of analysis of recombinant adenoviruses for gene therapy of cystic fibrosis. Hum Gene Ther 4:461–476
    Google Scholar
  125. Ridoux V, Robert JJ, Zhang X, Perricaudet M, Mallet J, Le Gal La Salle G (1994) Adenoviral vectors as functional retrograde neuronal tracers. Brain Res 648:171–175
    Google Scholar
  126. Romani M, De Ambrosis A, Alhadeff B, Purrello M, Gluzman Y, Siniscalco M (1990) Preferential integration of the Ad5/SV 40 hybrid virus at the highly recombinogenic human chromosomal site 1p36. Gene 95:231–241
    Google Scholar
  127. Roy N, Mahadevan MS, McLean M, Shutler G, Yaraghi Z, Farahnl R, Baird S, Besner-Johnston A, Lefebrve C, Xang X, Salih M, Aubry H, Tamai K, Guan X, Ioannou P, Crawford O, de Jong PJ, Surh L, Ikeda J-E, Korneluk RG, MacKenzie A (1995) The gene for neural apoptosis inhibitory protein is partially deleted in individuals with spinal muscular atrophy. Cell 80:167–168
    Google Scholar
  128. Ruben M, Bacchetti S, Graham F (1983) Covalently closed circles of adenovirus 5 DNA. Nature 301:172–174
    Google Scholar
  129. Sahenk Z, Seharaseyon J, Mendell JR, Burghes AHM (1993) Gene delivery to spinal motor neurons. Brain Res 606:126–129
    Google Scholar
  130. Salvatori G, Ferrari G, Messogiorno A, Servidei S, Colette M, Tonali P, Giarassi R, Cosso G, Mavillio F (1993) Retroviral vector-mediated gene transfer into human primary myogenic cells lead to expression in muscle fibers in vivo. Hum Gene Ther 4:713–723
    Google Scholar
  131. Seth P, Rosenfeld M, Higginbotham J, Crystal R (1994) Mechanism of enhancement of DNA expression consequent to cointernalization of a replication-deficient adenovirus and unmodified plasmid DNA. J Virol 68:93–940
    Google Scholar
  132. Setoguchi Y, Jaffe HA, Chu C-S, Crystal RG (1994) Intraperitoneal in vivo gene therapy to deliver α1-antitrypsin to the systemic circulation. Am J Respir Cell Mol Biol 10:369–377
    Google Scholar
  133. Sharp NJH, Kornegay JN, Van Camp SD (1992) An error in dystrophin mRNA processing in golden retriever muscular dystrophy an animal homologue of Duchenne muscular dystrophy. Genomics 13:115–121
    Google Scholar
  134. Shenk T, Jones N, Colby W, Fowlkes D (1979) Functional analysis of adenovirus-5 host-range deletion mutants defective for transformation of rat embryo cells. Cold Spring Harbor Symp 44:367–375
    Google Scholar
  135. Sicinski P, Geng Y, Ryder-Cook AS, Barnard EA, Darlison MG, Barnard PJ (1989) The molecular basis of muscular dystrophy in the mdx mouse: a point mutation. Science 244:1578–1580
    Google Scholar
  136. Slater GR, Harris JB (1994) The anatomy and physiology of the motor unit. In: Walton J, Karpati G, Hilton-Jones D (eds) Disorders of voluntary muscle. Churchill Livingstone, Edinburgh, pp 3–32
    Google Scholar
  137. Smith WR, Claycomb WC (1989) Expression of alpha and beta myosin heavy chain in the rat ventricular cardiac muscle cell. In: Kedes LR, Stockdale FE (eds) Cellular and molecular biology of muscle development. UCLA Symposia on Molecular and Cellular Biology New Series, vol 93. Liss, New York, pp 359–368
    Google Scholar
  138. Smith CL, Hager GL, Pike JW, Marx SJ (1991) Overexpression of the human vitamin D3 receptor in mammalian cells using recombinant adenovirus vectors. Mol Endocrinol 5:867–878
    Google Scholar
  139. Smith TA, Mehaffey MG, Kayda DB, Saunders JM, Yei S, Trapnell BC, McClelland A, Kaleko M (1993) Adenovirus mediated expression of therapeutic plasma levels of human factor IX in mice. Nature Genet 5:397–402
    Google Scholar
  140. Spergel JM, Hsu W, Akira S, Thimmapaya B, Kishimoto T, Cheng-Kiang S (1992) NF-IL6 a member of C/EBP family regulates E1A responsive promoters in absence of E1A. J Virol 66:1021–1030
    Google Scholar
  141. Stedman HH, Sweeney HL Shrager JB, Maguire HC, Panettieri RA, Petrof B, Narusawa M, Leferovich JM, Sladky JT, Kelly AM (1991) The mdx mouse diaphragm reproduces the degenerative changes of Duchenne muscular dystrophy. Nature 352:536–538
    Google Scholar
  142. Stillman B (1986) Functions of the adenovirus tumour antigens. Cancer Surv 5:390–402
    Google Scholar
  143. Stratford-Perricaudet LD, Levrero M, Chasse J-F, Prricaudet M, Briand P (1990) Evaluation of the transfer and expression in mice of an enzyme-encoding gene using a human adenovirus vector. Hum Gene Ther 1:241–256
    Google Scholar
  144. Stratford-Perricaudet LD, Briand P, Perricaudet M (1992) Feasibility of adenovirus mediated gene transfer in vivo. Bone Marrow Transpl 9:151–152
    Google Scholar
  145. Stratford-Perricaudet LD, Makeh I, Perricaudet M, Briand P (1992) Widespread long-term gene transfer to mouse skeletal muscles and heart via an adenovirus vector. J Clin Invest 90:626–630
    Google Scholar
  146. Stratford-Perricaudet LD, Perricaudet M (1994) Gene therapy: the advent of adenovirus. In: Wolff JA (ed) Gene therapeutics: methods and applications of direct gene transfer. Birkhäuser, Boston, pp 344–362
    Google Scholar
  147. Thimmappaya BC, Weinberger RJ, Schneider RJ, Shenk T (1982) Adenovirus VA I RNA is required for efficient translation of viral mRNAs at late times after infection. Cell 31:543–551
    Google Scholar
  148. Thompson DB, Booth FW (1991) Stable incorporation of a bacterial gene into adult rat muscle in vivo. Am J Physiol 258:578–581
    Google Scholar
  149. Trapnell BC, Chu CS, Paakko PK, Banks TC, Yoshimura K, Ferrans VJ, Chernik MS, Crystal RG (1991) Expression of the cystic fibrosis transmembrane conductance regulator gene in the respiratory tract of normal individuals and individuals with cystic fibrosis. Proc Natl Acad Sci USA 88:6565–6569
    Google Scholar
  150. Trapnell BC, Gorzilia M (1994) Gene therapy using adenoviral vectors. Curr Opinion Biotech 5:617–625
    Google Scholar
  151. Van Doren K, Hanahan D, Gluzman Y (1984) Infection of eukaryotic cells be helper-independent recombinant adenoviruses: early region 1 is not obligatory for integration of viral DNA. J Virol 50:606–614
    Google Scholar
  152. Van Ormondt H, Galibert F (1984) Nucleotide sequence of adenovirus DNAs. Curr Top Immunol 110:73–142
    Google Scholar
  153. Vincent N, Ragot T, Gilgenkrantz H, Couton D, Chafey P, Gregoire A, Briand P, Kaplan J, Kahn A, Perricaudet M (1994) Long-term correction of mouse dystrophic degeneration by adenovirus-mediated transfer of a minidystrophin gene. Nature Genet 5:130–134
    Google Scholar
  154. Vitadello M, Schiaffino MV, Picard A, Scarpa M, Schiaffino S (1994) Gene transfer in regenerating muscle Hum Gene Ther 5:11–18
    Google Scholar
  155. Wagner RW (1994) Gene inhibition using antisense oligodeoxynucleotides. Nature 372:333–335
    Google Scholar
  156. Wagner E, Zatloukal K, Cotten M, Birnstiel ML (1992) Coupling of adenovirus to transferrin-polylysin-DNA complexes greatly enhances receptor mediated gene delivery and expression of transfected genes. Proc Natl Acad Sci USA 89:6099–6103
    Google Scholar
  157. Walsh FS, Doherty P (1994) Cell biology of muscle. In: Walton J, Karpati G, Hilton-Jones D (eds) Disorders of voluntary muscle. Churchill Livingstone, Edinburgh, pp 33–61
    Google Scholar
  158. Watson JD, Hopkins NH, Steitz JA, Weiner AL (1987) Molecular biology of genes. Benjamin/Cummings, Menlo Park, pp 929–933
    Google Scholar
  159. Weiden M, Ginsberg H (1994) Deletion of the E4 region of the genome produces adenovirus DNA concatemers. Proc Natl Acad Sci USA 91:153–157
    Google Scholar
  160. Weinberg D, Ketner G (1983) A cell line that supports the growth of a defective early region 4 deletion mutant of human adenovirus type 2. Proc Natl Acad Sci USA 80:5383–5386.
    Google Scholar
  161. Weinberg D, Ketner G (1986) Adenoviral early region 4 is required for efficient viral DNA replication and for late gene expression. J Virol 57:833–838
    Google Scholar
  162. Wells DJ, Wells KE, Walsh FS, Davies KE, Goldspink G, Love DR, Chan-Thomas P, Dunckley MG, Piper T, Dickson G (1992) Human dystrophin expression corrects the myopathic phenotype in transgenic mdx mice. Hum Mol Genet 1:35–40
    Google Scholar
  163. Wikham TJ Mathias P Cheres DA, Nemerow GR (1993) Integrins αvβ3 and αvβ5 promote adenovirus internalization but not virus attachment. Cell 73:309–319
    Google Scholar
  164. Wold WSM, Hermiston TW, Tollefson A (1994) Adenovirus proteins that subvert host defenses. Trends Microbiol 2:437–444
    Google Scholar
  165. Wolff JA, Malone R, Williams P, Chong W, Acsadi G, Jani A, Felgner PL (1990) Direct gene transfer into mouse muscle in vivo. Science 247:1465–1468.
    Google Scholar
  166. Wolff JA, Ludtke JJ, Acsadi G, Jani A (1992) Long-term persistence of plasmid DNA and foreign gene expression in mouse muscle. Hum Mol Genet 1:363–369
    Google Scholar
  167. Wolff JA, Dowty ME, Jiao S, Repetto G, Berg RK, Ludtke JJ, Williams P (1992) Expression of naked plasmids by cultured myotubes and entry of plasmids into T tubules caveolae of mammalian skeletal muscle. J Cell Sci 103:1249–1259
    Google Scholar
  168. Wolff JA, Lederberg J (1994) An early history of gene transfer and therapy. Hum Gene Ther 469–480
  169. Yamada M, Lewis JA, Grodzicker T (1985) Overproduction of the protein product of a nonselected foreign gene carried by an adenovirus vector. Proc Natl Acad Sci USA 82:3567–3571
    Google Scholar
  170. Yang NS, Burkholder J, Roberts B, Martinelli B, McCabe D (1990) In vivo and in vitro gene transfer to mammalian somatic cells by particle bombardement. Proc Natl Acad Sci USA 87:9568–9572
    Google Scholar
  171. Yang Y, Nunes FA, Berencsi K, Furth EE, Gšnczšl E, Wilson JM (1994) Cellular immunity to viral antigens limits El-deleted adenoviruses for gene therapy. Proc Natl Acad Sci USA 91:4407–4441
    Google Scholar
  172. Yei S, Mittereder N, Wert S, Whitsett J, Wilmott R, Trapnell B (1994) In vivo evaluation of the safety of adenovirus-mediated transfer of the human cystic fibrosis transmembrane conductance regulator cDNA to the lung. Hum Gene Ther 5:731–744
    Google Scholar
  173. Yoshimura K, Rosenfeld MA, Seth P, Crystal R (1993) Adenovirus-mediated augmentation of cell transfection with unmodified plasmid vectors. J Biol Chem 268 2300–2303
    Google Scholar
  174. Zhu X, Young CSH, Silverstein S (1988) Adenovirus vector expressing functional herpes simplex virus ICPO. J Virol 62:4544–4553
    Google Scholar
  175. Zubrzycka-Gaarn EF, Bulman DF, Karpati G, Burghes HHM, Belfall B, Klamut HJ, Talbot J, Hodges RS, Ray PN, Worton RG (1988) The Duchenne muscular dystrophy gene product is localized in sarcolemma of human skeletal muscle. Nature 333:466–469
    Google Scholar

Download references